{
    "2018-11-05": [
        [
            {
                "time": "2018-11-06",
                "original_text": "【中银医药】医药生物行业2018年三季报综述——行业整体收入和扣非利润保持20%的增速中枢",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "收入",
                        "扣非利润",
                        "增速"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-06",
                "original_text": "华兰生物：参股公司取得药物临床试验批件",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "参股公司",
                        "药物",
                        "临床试验",
                        "批件"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-06",
                "original_text": "流感旺季节来临 疫苗概念有望持续修复",
                "features": {
                    "keywords": [
                        "流感",
                        "疫苗",
                        "概念",
                        "修复"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "操盘必读：11月5日证券市场要闻",
                "features": {
                    "keywords": [
                        "操盘",
                        "证券市场",
                        "要闻"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-06",
                "original_text": "医药行业2018年三季报总结:医药分化加剧,把握产业龙头",
                "features": {
                    "keywords": [
                        "医药行业",
                        "三季报",
                        "分化",
                        "产业龙头"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}